Pharmaceutical companies appeared "code of honor"

The Association of International Pharmaceutical Manufacturers (AIPM), bringing together more than 50 international companies issued a Code of Good Practice. This document differs from the existing since 2009 Code of marketing practices that regulates not only advertising, but also other activities of manufacturers of medicines.

Code for pharmaceutical manufacturers

Drawing Code of Good Practice   explains the significant changes in the Russian legislation (which came into force in 2011, the law "On protection of health of citizens of the Russian Federation") and the adoption of the new edition of the Code of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), which includes AIPM.
Code of Good Practice prescribes:
- The rules of interaction with healthcare professionals, patient organizations, pharmacies / pharmacy chains,
- Postmarketing clinical, observational, epidemiological and market research,
- Distribution of pharmaceutical companies or organizations representing their interests, information relevant to the health and human diseases,
- Promotional activities for health workers,
- Use of the Internet and other digital communication channels for the promotion of pharmaceutical products.
In the preface to this document is an appeal Acting Head of the Federal Service for Supervision of Health. This is particularly important as it Roszdravnadzor is the authorized body for the verification of compliance with medical and pharmaceutical workers statutory restrictions.

"This Code sets high ethical standards of the pharmaceutical companies", - says Director of the Institute of Legislation and Comparative Law under the Government of the Russian Federation, Doctor of Law, Academician Waist Habrieva.

  She noted that to comply with the norms prescribed by this document should not only members of the AIPM, but also to all drug manufacturers, operating on the territory of our country.
Vladimir Shipkov, executive director of the "Association of International Pharmaceutical Manufacturers", added that report violations of the Code may be every citizen. Any appeal will be considered carefully and impartially.

"The efforts being made by the Russian Ministry of Health for the legislative regulation of the health care and pharmaceutical companies interactions with the medical community are huge, but the real practice of the new laws formed a long time. Code - a "living and moving" self-regulation format and requirements that it puts even more stringent than legal restrictions, "- said Madina Pliev, Director of Legal Affairs AIPM.

  (READ MORE)

Industry News

Go back to the main page